LAVA Therapeutics’ Nasdaq IPO

NautaDutilh assisted LAVA Therapeutics B.V. on the deal. LAVA Therapeutics B.V. (Nasdaq: LVTX) closed its IPO on the Nasdaq Global Market, raising approximately USD 100 million...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Emburse’s Acquisition of Roadmap

NautaDutilh assisted Emburse with its acquisition of Roadmap. Emburse (backed by K1 Investment Management) completed the  acquisition of Roadmap.  One unintended benefit of the pandemic-induced travel...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here